Ligand Pharmaceuticals (LGND) Inventory (2011 - 2026)
Ligand Pharmaceuticals recorded quarterly Inventory of $13.3 million in Q1 2026, up 45.36% quarter-over-quarter from $9.1 million in Q4 2025, and down 9.22% year-over-year from $14.6 million in Q1 2025.
Ligand Pharmaceuticals' Inventory history runs 16 years deep, the most recent figure standing at $13.3 million for Q1 2026.
- In Q1 2026, Inventory fell 9.22% year-over-year to $13.3 million; the TTM figure through Mar 2026 stood at $13.3 million (down 9.22% YoY), while the FY2025 annual figure was $9.1 million, down 35.34% from the prior year.
- Inventory came in at $13.3 million for Q1 2026 at Ligand Pharmaceuticals, up from $9.1 million in the prior quarter.
- In the past five years, Inventory ranged from a high of $26.9 million in Q2 2023 to a low of $9.1 million in Q4 2025.
- A 5-year average of $18.3 million and a median of $16.7 million in 2024 frame the typical range for Inventory.
- Across the five-year window, Inventory tumbled 51.35% in 2022 and soared 80.3% in 2023, its largest moves.
- Ligand Pharmaceuticals' Inventory stood at $13.3 million in 2022, then jumped by 80.3% to $24.0 million in 2023, then sank by 41.12% to $14.1 million in 2024, then plunged by 35.34% to $9.1 million in 2025, then soared by 45.36% to $13.3 million in 2026.
- According to Business Quant data, Inventory over the past three periods registered $13.3 million, $9.1 million, and $11.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 32.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.77 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.10 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 84.03 Mn |
| 10 | Ligand Pharmaceuticals | 4.55 Bn | 3.77 Bn | 48.45 Mn | 13.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.27 Mn |
| Dec 31, 2025 | 9.13 Mn |
| Sep 30, 2025 | 11.90 Mn |
| Jun 30, 2025 | 15.49 Mn |
| Mar 31, 2025 | 14.61 Mn |
| Dec 31, 2024 | 14.11 Mn |
| Sep 30, 2024 | 16.74 Mn |
| Jun 30, 2024 | 18.67 Mn |
| Mar 31, 2024 | 21.34 Mn |
| Dec 31, 2023 | 23.97 Mn |
| Sep 30, 2023 | 25.39 Mn |
| Jun 30, 2023 | 26.91 Mn |
| Mar 31, 2023 | 14.01 Mn |
| Dec 31, 2022 | 13.29 Mn |
| Sep 30, 2022 | 22.33 Mn |
| Jun 30, 2022 | 24.77 Mn |
| Mar 31, 2022 | 25.61 Mn |
| Dec 31, 2021 | 27.33 Mn |
| Sep 30, 2021 | 33.00 Mn |
| Jun 30, 2021 | 39.95 Mn |
| Mar 31, 2021 | 36.93 Mn |
| Dec 31, 2020 | 26.49 Mn |
| Sep 30, 2020 | 13.43 Mn |
| Jun 30, 2020 | 3.70 Mn |
| Mar 31, 2020 | 7.32 Mn |
| Dec 31, 2019 | 7.30 Mn |
| Sep 30, 2019 | 6.57 Mn |
| Jun 30, 2019 | 9.64 Mn |
| Mar 31, 2019 | 11.91 Mn |
| Dec 31, 2018 | 7.12 Mn |
| Sep 30, 2018 | 8.14 Mn |
| Jun 30, 2018 | 9.52 Mn |
| Mar 31, 2018 | 10.53 Mn |
| Dec 31, 2017 | 4.37 Mn |
| Sep 30, 2017 | 5.01 Mn |
| Jun 30, 2017 | 6.81 Mn |
| Mar 31, 2017 | 7.63 Mn |
| Dec 31, 2016 | 1.92 Mn |
| Jun 30, 2016 | 3.84 Mn |
| Mar 31, 2016 | 1.75 Mn |
| Dec 31, 2015 | 1.63 Mn |
| Sep 30, 2015 | 1.22 Mn |
| Jun 30, 2015 | 802,000.00 |
| Mar 31, 2015 | 2.82 Mn |
| Dec 31, 2014 | 269,000.00 |
| Sep 30, 2014 | 1.07 Mn |
| Jun 30, 2014 | 817,000.00 |
| Mar 31, 2014 | 1.95 Mn |
| Dec 31, 2013 | 1.39 Mn |
| Sep 30, 2013 | 1.84 Mn |
| Jun 30, 2013 | 2.27 Mn |
| Mar 31, 2013 | 2.84 Mn |
| Dec 31, 2012 | 1.70 Mn |
| Sep 30, 2012 | 2.55 Mn |
| Mar 31, 2012 | 1.35 Mn |
| Dec 31, 2011 | 1.30 Mn |
| Sep 30, 2011 | 1.96 Mn |
| Jun 30, 2011 | 2.59 Mn |